Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole
- 1 February 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (2) , 911
- https://doi.org/10.1128/jcm.41.2.911.2003
Abstract
We recently described the recovery of six clinical isolates of Trichosporon asahii from nongranulocytopenic patients that exhibited reduced susceptibilities to amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole ([7][1]). In a recent paper Paphitou et al. reported ([6][2]) thatThis publication has 8 references indexed in Scilit:
- Antifungal drug resistance to azoles and polyenesThe Lancet Infectious Diseases, 2002
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Voriconazole -- better chances for patients with invasive mycoses.2002
- In Vitro Antifungal Susceptibilities of Trichosporon SpeciesAntimicrobial Agents and Chemotherapy, 2002
- Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care UnitsJournal of Clinical Microbiology, 2001
- In vitro activity of voriconazole against selected fungi.1998
- In vitro activity of voriconazole against selected fungiMedical Mycology, 1998
- In vitroactivity of voriconazole against selected fungiMedical Mycology, 1998